Balb/c 3T3 cells contain a large number [(0.8-1.6) x 1061 of high-affinity (half-maximal binding at 0.2 nM) binding sites for cholera toxin that are resistant to proteolysis, but are quantitatively extracted with chloroform/methanol. The following evidence rigorously establishes that the receptor is a ganglioside similar to, or identical with, ganglioside GM1.
ganglioside labelled when total cellular gangliosides separated on silica-gel sheets were overlayed with 1251I-labelled cholera toxin, although GM3 and GD1a were the major gangliosides present. In contrast no evidence for a galactoprotein with receptor activity was obtained. Cholera toxin did not protect the terminal galactose residues of cell-surface glycoproteins from labelling by the galactose oxidase/NaB3H4 technique.
No toxin-binding proteins could be identified in Nonidet P40 extracts of [35] l methionine-labelled cells by immunochemical means. After sodium dodecyl sulphate/polyacrylamide-gel electrophoresis none of the major cellular galactoproteins identified by overlaying gels with 125I-labelled ricin were able to bind '25I-labelled cholera toxin. It is concluded that the cholera toxin receptor on Balb/c 3T3 cells is exclusively ganglioside GM, (or a related species), and that cholera toxin can therefore be used to probe the function and organisation of gangliosides in these cells as previously outlined [Critchley, Ansell, Perkins, Dilks & Ingram (1979) J. Supramol. Struct. 12, 273-2911. Amongst the many changes that accompany tumour-virus transformation of animal cells in culture is loss of the ability to synthesize the more complex glycosphingolipids. Although the observation is well documented, little headway has been made in clarifying its significance with respect to other characteristics of the transformed phenotype, but a role for glycosphingolipids in cellular interaction has been proposed (for reviews see Critchley & Vicker, 1977; Hakomori, 1981) . The demonstration that ganglioside GM1 (ganglioside nomen-clature is according to Svennerholm, 1963) can act as a cell-surface receptor for cholera toxin , and that a variety of other ligands can bind to glycosphingolipids (Kohn, 1978; Critchley et al., 1979a; Hakomori, 1981) (Critchley et al., 1979b) . To investigate this approach we have chosen a cell line Balb/c 3T3, which has a large number of receptors for cholera toxin, and which on transformation by SV40 or polyoma virus is reported to show reduced synthesis of complex gangliosides, including ganglioside GM, (Brady & Mora, 1970) . However, before undertaking the mutant selection programme we felt it necessary to establish directly that the cholera toxin receptor in these cells was exclusively ganglioside (GM1) for the following reasons. (a) Although there is no doubt that cholera toxin binds to ganglioside GM, (Cuatrecasas, 1973; Holmgren et al., 1973) , the evidence that ganglioside GM1 acts as the cell-surface receptor is almost entirely indirect Moss et al., 1977) and the possibility that the receptor activity might be carried on a glycoprotein has not been rigorously excluded. (b) The cholera toxin receptor on rat intestinal brush borders has indeed been reported to be a heterogeneous collection of galactoproteins (Morita et al., 1980) . (c) Anti-(ganglioside GM 1) antibodies reportedly cross-react with galactoproteins on the surface of Balb/c 3T3 cells (Tonegawa & Hakomori, 1977) . (d) It is known that antigenic determinants of the ABH blood group system (Fukuda et al., 1979) and Forssman activity (Slomiany et al., 1981) can be found on both glycosphingolipids and glycoproteins. (e) Some evidence that similar carbohydrate sequences are frequently present on both types of molecule has been presented (Rauvala & Finne, 1979) . (f) Evidence that the glycoprotein hormone receptors involve both glycosphingolipids and glycoproteins has been reported (Mullin et al., 1976; Kohn, 1978) , although this has been disputed (Pacuszka et al., 1978) .
In this paper we now provide definitive evidence Iodination ofcholera toxin and ricin Cholera toxin (Schwarz-Mann, Orangeburg, NY, U.S.A.) was iodinated as previously outlined (Streuli et al., 1981) . Ricin (RCA60; Miles Biochemicals) was iodinated as described by Burridge (1978) . For trypsin-and proteinase-treatment studies the supernatants were spun in a Beckman microfuge for 10min at 40C to pellet only the larger particulate material. Trypsin or proteinase treatment of membranes leads to a reduction in size of the particles to an extent where they are not quantitatively retained by 0.2,um filters. Unless only those membranes that can be pelleted in the microfuge are used, trypsin (50 and 200,ug/ml) produces an apparent 20 and 30% reduction respectively in the ability of the membranes to bind '25I-labelled cholera toxin.
Surface-labelling procedures
Terminal galactose or N-acetylgalactosamine residues in cell-surface glycosphingolipids and glycoproteins were labelled with 3H by incubating confluent cell monolayers with galactose oxidase (Worthington Biochemicals) followed by reduction with NaB3H4 (Critchley, 1974) . Cell-surface sialic acid residues were similarly labelled with 3H after incubation of cell monolayers with 5 mM-NaIO4 in phosphate-buffered saline/PMSF (Critchley et al., 1976) .
Metabolic labelling
Proteins were labelled by incubating sub-confluent monolayers overnight in methionine-free medium (plus 10% calf serum) containing [1] [2] [3] [4] [5] uCi (Critchley & Macpherson, 1973) .
Isolation of the cholera toxin receptor by immune adsorption
The cholera-toxin receptor was isolated from cells labelled by one of these procedures as previously described (Critchley et al., 1979b (Kessler, 1975) . The bacteria were pelleted in a microfuge for 2 min, and the pellet was subsequently washed three to five times either with 0.05% (v/v) Nonidet P40/NET buffer/0.2% (w/v) gelatin ([1-14Clpalmitate or galactose oxidase/ NaB3H4 experiments) or with 1% Triton/1% deoxycholate/0. 1% sodium dodecyl sulphate in NET buffer (Rohrschneider et al., 1979) (315Slmethionine experiments). Proteins adsorbed to the bacterial pellets were solubilized by boiling for 3 min with 9 Murea/1% sodium dodecyl sulphate/1% mercaptoethanol in 0.15 M-Tris, pH 6.8. Labelled proteins were separated in sodium dodecyl sulphate/polyacrylamide gels (Laemmli, 1970) and detected by fluorography (Laskey & Mills, 1975 (Svennerholm, 1957) . Binding of 125I-labelled cholera toxin to gangliosides ofBalb/c 3T3 cells Total cellular lipids or more usually a purified ganglioside fraction were separated on plastic-backed silica gel chromatography sheets (10 cm x 10 cm; Eastman Kodak) with chloroform/methanol/water (60:35:8, by vol.) as solvent. After drying, the sheets were overlayed with 5-7ml of phosphatebuffered saline containing 1% polyvinylpyrrolidone [poly(vinylpyrrolidin-2-one)l followed by 1251_ labelled cholera toxin (2 x 106c.p.m./ml) in the same buffer, as described by Magnani et al. (1980) . The sheets were incubated for between 40 and 120min at 4°C, washed three times with phosphate-buffered saline containing 1% polyvinylpyrrolidone, dried and autoradiographed. The specificity of 125I-labelled toxin binding was established by pre-incubating sheets with S ,ug of unlabelled toxin/ml.
Visual detection of cholera toxin and ricin-binding molecules after sodium dodecyl sulphate!polyacrylamide-gel electrophoresis Cholera toxin and ricin-binding molecules of Balb/c 3T3 cells were detected in sodium dodecyl sulphate polyacrylamide gels essentially as described by Burridge (1978) . Gel slices were overlaid with Tris/saline buffer (0.15 M-NaCl/50 mM-Tris/ 0.05% NaN3, at pH7.5)/0.1% bovine serum albumin containing either 2x 106c.p.m./ml of cholera toxin (sp. radioactivity approx. 1OCi/g) or 8 x 106 c.p.m./ml of 125I-labelled ricin (sp. radioactivity 4 Ci/g).
Results
Binding ofcholera toxin to Balb/c 3T3 was no evidence for a gradual increase in toxin binding above this concentration (Fig. la) . Halfmaximal binding occurred at 0.2 nm. In addition binding of 1251I-labelled cholera toxin (0.34nM) was inhibited >90% by unlabelled 10nM toxin (Fig. lb) Effect of cholera toxin on labelling of ganglioside GM, by the galactose oxidase/NaB3H4 method To obtain more direct evidence that ganglioside GM1 is the cholera toxin receptor, the ability to label the terminal galactose residue of cell-surface ganglioside GMi using galactose oxidase/NaB3H4 was studied in the presence and absence of cholera toxin. Fig. 2(b) shows that a ganglioside with chromatographic properties of GM1 can be labelled at the surface of Balb/c 3T3 cells in the presence of galactose oxidase. Labelling in the absence of enzyme was largely restricted to a component that travelled close to the solvent front (Fig. 2a) .
Labelling of ganglioside GM1 by galactose oxidase/ NaB3H4 was quantitatively abolished if the cells were first pre-incubated with 60nm cholera toxin (Fig. 2c) . Although the results strongly support the idea that the toxin receptor in Balb/c 3T3 cells is ganglioside GMI, the possibility that the above result was due to steric hindrance cannot be excluded.
Identiflcation of the cholera toxin receptor by immunoadsorption
To provide more direct evidence concerning the involvement of ganglioside GM1 in toxin binding we have attempted to isolate the toxin receptor using immunochemical means. In brief, cells labelled by the galactose oxidase/NaB3H4 method were incubated with cholera toxin, putative toxin-receptor complexes solubilized in 1% Nonidet P40 and, after addition of toxin antibodies, the immune complexes were adsorbed on to protein A-containing strains of S. aureus. To increase the amount of ganglioside GM1 available to galactose oxidase and cholera toxin, (Fig. 4a) .
Cholera toxin was bound to the surface of such metabolically labelled cells and toxin receptors isolated from a 1% Nonidet P40 cell extract using immunoadsorption. Again ganglioside GM) was the Vol. 204 only ganglioside specifically adsorbed using this procedure (Figs. 4d and 4e) , the amount isolated being greater if the cells were first incubated with neuraminidase ( Figs. 4b and 4c ). There was no adsorption of ganglioside GM) if pre-immune rabbit serum was used, or if cells were not exposed to cholera toxin. Although ganglioside GM3 adsorbed non-specifically to S. aureus, the levels present did increase under conditions where ganglioside GM1 was specifically adsorbed, although the extent of the increase was somewhat variable.
Specificity of cholera toxin-ganglioside GM) interaction
To clarify more precisely the specificity of binding of cholera toxin to various gangliosides, lipid extracts of Balb/c 3T3 cells were chromatographed on silica-gel-coated plastic sheets, which were then overlayed with 125I-labelled cholera toxin as described by Magnani et al. (1980) . After washing, bound 251I-labelled toxin was detected by autoradiography. Toxin was restricted to a component with a similar mobility to ganglioside GM1 (Figs. 5a-5f). There was no labelling of GM3 or GDla' quantitatively the major gangliosides of Balb/c 3T3 cells, and there was no significant labelling at the origin, as would be expected if a toxin-binding protein had been extracted by organic solvents. Labelling of ganglioside GM) by 125I-labelled toxin appeared to be specific in that it was abolished by pre-incubation of the silica gel sheet with unlabelled incubated with or without cholera toxin (60nM) for 30min at 37°C in phosphate-buffered saline (Ca2+, Mg2+)/1 mM-PMSF, followed by a 3 h incubation after the addition of galactose oxidase (20units/ml). The cells were labelled with 3H by addition of NaB3H4 in suspension, and the gangliosides were purified and separated by t.l.c. as described in the Materials and methods section. After visual detection of the ganglioside standards with 12 vapour. 0.25cm divisions were marked on the t.l.c. plate starting below the origin (0), and the silica gel toxin (Fig. 5g) . There thus seems no doubt that ganglioside GM1 does act as a cholera toxin receptor on the surface of Balb/c 3T3 cells, and we therefore turned our attention to establishing whether or not galactoproteins also bind cholera toxin in these cells. Immunochemical approach to the identification of proteins that bind cholera toxin By using the immunochemical approach outlined, we had previously found that a galactoprotein (mol.wt. 84000) could be isolated from Balb/c 3T3 cells labelled by the galactose oxidase/NaB3H4 method under conditions where ganglioside GMI was specifically adsorbed (Critchley et al., 1 979b) . However, the galactoprotein contained <10% of the label specifically adsorbed. In an attempt to extend this observation further we used cells labelled with [ 35Slmethionine because of the ease of labelling total cellular protein to high specific activity. We obtained no evidence that a protein of mol.wt. 84000, or indeed any other cellular protein, could be specifically adsorbed to S. aureus from Nonidet P40 extracts of [35Slmethionine-labelled cells in the presence of cholera toxin and antitoxin. The result was identical whether the toxin was bound to the cell before Nonidet P40 extraction, or the toxin added directly to the detergent extract. However, the approach is dependent on the ability to solubilize putative toxin-receptors in detergent, and during the course of this work it became clear that much of the toxin bound to cells before detergent extraction remained associated with material that could be sedimented at lOOOOOg (Streuli et al., 1981) . The possibility that this material contained toxin receptor activity, possibly galactoprotein in nature, had therefore to be considered.
Effect of cholera toxin on labelling of galactoproteins by the galactose oxidase/NaB3H4 method
In an attempt to provide definitive evidence for or against such a galactoprotein able to bind cholera toxin, we used two additional approaches that did not rely on the ability to solubilize toxin-receptor complexes in neutral detergents. First as cholera toxin effectively blocked labelling of cell surface GM I by the galactose oxidase/NaB3H4 procedure (Fig. 2) , we used the delipidated residues from the same experiments to look for evidence for a similar protection of galactoprotein labelling. Fig. 6(c) shows that a number of cell-surface galactoproteins transferred to vials for scintillation counting. 104-/NaB3H4 methods were also directly analysed to give the ganglioside-labelling patterns of the whole were also labelled by the galactose oxidase/NaB3H4 procedure, and that in the absence of enzyme, labelling was restricted to a protein with a mol.wt. of 55000 (Fig. 6b) . Although labelling of ganglioside GM1 was inhibited in the presence of cholera toxin (Fig. 2) , the same preparations showed no inhibition of labelling of cell-surface galactoproteins (Fig. 6d) . That delipidation did not lead to a significant alteration in galactoprotein profile compared with that of the whole cell is shown in Fig. 6(e) . The only major difference between the two preparations was the presence of a band below the dye front in unextracted cells, which probably represented labelled lipid.
Identification of the cholera toxin receptor in Balbic *3T3 cells using sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and a 125I-labelled toxin overlay technique Our second approach was to separate total cell protein by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and to overlay the gels with 1251-labelled cholera toxin. After extensive washing, toxin-binding components were identified by autoradiography. Fig. 7(a) shows that all of the bound toxin was localized in a region around the marker-dye front, and that the labelling was almost completely abolished by pre-incubating the gel with an excess of unlabelled toxin Fig. 7(b) . The major cellular galactoproteins localized by overlaying with 125I-labelled ricin (mol.wt. 95000-110000; Fig. 7c ) were similar in size to the major galactoproteins labelled by the galactose oxidase/NaB3H4 procedure. None of these galactoproteins were able to bind cholera toxin. Labelling of the component at the dye front by '25I-labelled toxin was decreased by 99% if the cells were first delipidated (Fig. 7d) , whereas labelling of galactoproteins by 125I-labelled ricin was unaffected (results not shown). Analysis of the chloroform/methanol extract by the sodium dodecyl sulphate/polyacrylamide-gel electrophoresis '251-labelled toxin overlay technique showed all the toxin binding capacity again localized at the dye front (results not shown), the region of the gel where ganglioside GM1 has previously been shown to migrate (Critchley et al., 1979b) . Finally the possibility that potential cholera toxin receptors exist on the surface of Balb/c 3T3 but are masked by sialic acid residues was considered. Treatment of cells with neuraminidase before sodium dodecyl sulphate/polyacrylamide-gel electrophoresis increased the levels of '251-labelled cholera toxin binding to the dye front approx. 2-fold (Figs. 7e and 7f). (In this experiment multiple bands of toxin binding activity appeared just behind the dye front, which we believe to be an artefact due to sample overloading. Such banding was quantitatively abolished by lipid extraction.) Neuraminidase treatment resulted in an even greater increase in the labelling of galactoproteins by 251I-labelled ricin (Figs. 7g and 7h ), but none of these were able to bind cholera toxin.
Discussion
The binding characteristics of 1251I-labelled cholera toxin to Balb/c 3T3 cells clearly show that there is a single class of high-affinity receptor that is resistant to proteolysis but quantitatively extracted by chloroform/methanol. This result provides immediate evidence that the toxin receptor is predominantly lipid in nature. The possibility that the extraction procedure has denatured receptor activity asso- Balb/c 3T3 cells are incubated with neuraminidase (Critchley & Vicker, 1977) . However, it might also be due to exposure of a similar carbohydrate sequence in glycoproteins.
The following evidence strongly supports-the conclusion that the major receptor for cholera toxin in Balb/c 3T3 cells is indeed ganglioside GM1. First, labelling by the galactose oxidase/NaB3H4 method of a cell-surface ganglioside with chromatographic properties similar to GMl is inhibited if the cells are first pre-incubated with cholera toxin. The data confirm the previous observation of Fishman and his co-workers in other cell systems (Critchley et al., 1979b) . One explanation for this discrepancy is that labelling specifically cell-surface galactoproteins, rather than total cellular proteins, increases the sensitivity of the method such that lower levels of proteins with toxin-binding activity can be detected. The fact that the same toxin-binding glycoproteins were not detected by the 125I-labelled toxin/gel overlay technique may also be due to the limited sensitivity of the method. An alternative explanation previously considered in some detail (Critchley et al., 1979b) is that mixed micelles containing ganglioside GM,-toxin complexes plus other contaminating components may be formed during the solubilization process. Such components would also be adsorbed on to the S. aureus in the presence of anti-toxin, along with the true toxin receptor. It might also account for (1) the increase in adsorption of ganglioside GM3 from Nonidet P40 extracts of [1-'4C]palmitate-labelled cells in the presence of anti-toxin, as ganglioside GM3 clearly does not bind cholera toxin, and (2) the apparent cross-reactivity of anti-(ganglioside GMI) antibodies with galactoproteins of Balb/c 3T3 cells (Tonegawa & Hakomori, 1977) . In experiments with [35S]-methionine-labelled cells we therefore washed the adsorbed immune complexes more rigorously (see the Materials and methods section) in an attempt to extract non-specifically adsorbed material, and there was no evidence for the specific adsorption of any labelled protein in the presence of toxin and anti-toxin.
In summary, although the ability of cholera toxin to bind to ganglioside GM1 in solution (Schwarzmann et al., 1978) and to GM1 inserted into cells and liposomes (Fishman et al., 1979) has previously been clearly demonstrated, the chemical nature of the endogenous receptor has never been rigorously investigated. In the present study we have provided direct evidence that the major receptor for cholera toxin in Balb/c 3T3 cells is indeed a ganglioside with chromatographic and labelling properties compatible with GM1. We have found no evidence -that galactoproteins contribute in any substantial way to the toxin-binding capacity of Balb/c 3T3 cells, although we cannot, and do not, exclude the possibility that a minor population of galactoproteins with toxinbinding activity exist in these cells. By using techniques similar to those described here, we have also recently presented strong evidence that the predominant species of toxin receptor in rat intestinal brush borders is again ganglioside GM1 . Although we were able to identify putative toxin-binding galactoproteins by immunochemical means, confirming in part a previous report by Morita et al. (1980) , our results do not suggest that they contribute in a major way (if at all) to the toxin-binding capacity of this system. However, the possibility that receptor activity might be carried by glycoproteins in other cell types should not be ignored (Hakomori, 1981) .
